Conmed logo

Conmed Share Price Today

(NASDAQ: CNMD)

Conmed share price is $57.6 & ₹5,009.41 as on 6 Mar 2025, 2.30 'hrs' IST

$57.6

-0.1

(-0.17%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Conmed share price in Dollar and Rupees. Guide to invest in Conmed stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Conmed, along with analyst recommendations, forecasts, and comprehensive financials.

Conmed share price movements

  • Today's Low: $56.85
    Today's High: $59.07

    Day's Volatility :3.77%

  • 52 Weeks Low: $55.22
    52 Weeks High: $86.96

    52 Weeks Volatility :36.5%

Conmed (CNMD) Returns

PeriodConmed CorpSector (Health Care)Index (Russel 2000)
3 Months
-20.65%
3.7%
0.0%
6 Months
-22.49%
-2.8%
0.0%
1 Year
-31.91%
2.5%
0.0%
3 Years
-58.94%
12.9%
-11.6%

Conmed (CNMD) Key Statistics

in dollars & INR

Previous Close
$57.7
Open
$58.28
Today's High
$59.07
Today's Low
$56.845
Market Capitalization
$1.8B
Today's Volume
$359.9K
52 Week High
$86.96
52 Week Low
$55.22
Revenue TTM
$1.3B
EBITDA
$229.7M
Earnings Per Share (EPS)
$4.25
PE Ratio
13.55
Dividend Yield
1.39%
Profit Margin
10.13%
Quarterly Earnings Growth YOY
0.03%
Return On Equity TTM
14.74%

How to invest in Conmed Stock (CNMD) from India?

It is very easy for Indian residents to invest directly in Conmed from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Conmed stock in both Indian Rupees (INR) and US Dollars (USD). Search for Conmed or CNMD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Conmed or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Conmed shares which would translate to 0.015 fractional shares of Conmed as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Conmed, in just a few clicks!

Returns in Conmed (CNMD) for Indian investors in Rupees

The Conmed stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Conmed investment value today

Current value as on today

₹73,042

Returns

₹26,958

(-26.96%)

Returns from Conmed Stock

₹31,907 (-31.91%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Conmed (CNMD)

-18%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Conmed Stock from India on INDmoney has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Conmed

  • BlackRock Inc

    15.97%

  • Vanguard Group Inc

    11.56%

  • Earnest Partners LLC

    9.09%

  • Capital Research Global Investors

    5.10%

  • State Street Corp

    4.39%

  • Champlain Investment Partners, LLC

    4.21%

Analyst Recommendation on Conmed

Buy

    71%Buy

    28%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Conmed(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
4
4
4
Sell
0
0
0

Analyst Forecast on Conmed Stock (CNMD)

What analysts predicted

Upside of 34.18%

Target:

$77.29

Current:

$57.60

Insights on Conmed Stock (Ticker Symbol: CNMD)

  • Price Movement

    In the last 1 month, CNMD stock has moved down by -14.5%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 316.70M → 345.94M (in $), with an average increase of 8.5% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 48.98M → 33.75M (in $), with an average decrease of 31.1% per quarter
  • CNMD vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 55.3% return, outperforming this stock by 87.2%
  • CNMD vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 138.2% return, outperforming this stock by 197.9%
  • Price to Sales

    ForCNMD every $1 of sales, investors are willing to pay $1.4, whereas for Boston Scientific Corp., the investors are paying $9.2 for every $1 of sales.

CNMD Conmed Financials in INR & Dollars

FY19Y/Y Change
Revenue
$955.1M
↑ 11.11%
Net Income
$28.6M
↓ 29.95%
Net Profit Margin
3.0%
↓ 1.75%
FY20Y/Y Change
Revenue
$862.5M
↓ 9.7%
Net Income
$9.5M
↓ 66.75%
Net Profit Margin
1.1%
↓ 1.9%
FY21Y/Y Change
Revenue
$1.0B
↑ 17.18%
Net Income
$62.5M
↑ 557.16%
Net Profit Margin
6.19%
↑ 5.09%
FY22Y/Y Change
Revenue
$1.0B
↑ 3.45%
Net Income
$-80.6M
↓ 228.84%
Net Profit Margin
-7.71%
↓ 13.9%
FY23Y/Y Change
Revenue
$1.2B
↑ 19.06%
Net Income
$64.5M
↓ 179.99%
Net Profit Margin
5.18%
↑ 12.89%
FY24Y/Y Change
Revenue
$1.3B
↑ 5.0%
Net Income
$132.4M
↑ 105.44%
Net Profit Margin
10.13%
↑ 4.95%
Q3 FY23Q/Q Change
Revenue
$304.6M
↓ 4.12%
Net Income
$15.8M
↑ 15.33%
Net Profit Margin
5.2%
↑ 0.88%
Q4 FY23Q/Q Change
Revenue
$327.0M
↑ 7.38%
Net Income
$33.1M
↑ 108.82%
Net Profit Margin
10.11%
↑ 4.91%
Q1 FY24Q/Q Change
Revenue
$311.6M
↓ 4.71%
Net Income
$19.7M
↓ 40.4%
Net Profit Margin
6.32%
↓ 3.79%
Q2 FY24Q/Q Change
Revenue
$330.7M
↑ 6.13%
Net Income
$30.0M
↑ 52.09%
Net Profit Margin
9.06%
↑ 2.74%
Q3 FY24Q/Q Change
Revenue
$316.7M
↓ 4.25%
Net Income
$49.0M
↑ 63.41%
Net Profit Margin
15.47%
↑ 6.41%
Q4 FY24Q/Q Change
Revenue
$345.9M
↑ 9.23%
Net Income
$33.8M
↓ 31.09%
Net Profit Margin
9.76%
↓ 5.71%
FY19Y/Y Change
Profit
$524.7M
↑ 11.85%
FY20Y/Y Change
Profit
$460.3M
↓ 12.28%
FY21Y/Y Change
Profit
$568.0M
↑ 23.41%
FY22Y/Y Change
Profit
$571.2M
↑ 0.56%
FY23Y/Y Change
Profit
$676.2M
↑ 18.38%
FY24Y/Y Change
Profit
$733.0M
↑ 8.4%
Q3 FY23Q/Q Change
Profit
$168.1M
↓ 1.54%
Q4 FY23Q/Q Change
Profit
$184.3M
↑ 9.68%
Q1 FY24Q/Q Change
Profit
$162.0M
↓ 12.13%
Q2 FY24Q/Q Change
Profit
$173.2M
↑ 6.9%
Q3 FY24Q/Q Change
Profit
$179.0M
↑ 3.37%
Q4 FY24Q/Q Change
Profit
$198.3M
↑ 10.81%
FY19Y/Y Change
Operating Cash Flow
$95.1M
↑ 27.35%
Investing Cash Flow
$-387.7M
↑ 2248.47%
Financing Cash Flow
$300.9M
↓ 516.36%
FY20Y/Y Change
Operating Cash Flow
$64.5M
↓ 32.17%
Investing Cash Flow
$-13.6M
↓ 96.48%
Financing Cash Flow
$-52.1M
↓ 117.3%
FY21Y/Y Change
Operating Cash Flow
$111.8M
↑ 73.2%
Investing Cash Flow
$-14.9M
↑ 9.0%
Financing Cash Flow
$-101.5M
↑ 95.06%
FY22Y/Y Change
Operating Cash Flow
$33.4M
↓ 70.15%
Investing Cash Flow
$-249.5M
↑ 1578.52%
Financing Cash Flow
$225.0M
↓ 321.57%
Q3 FY23Q/Q Change
Operating Cash Flow
$46.1M
↑ 72.94%
Investing Cash Flow
$-5.4M
↓ 2.44%
Financing Cash Flow
$-37.2M
↑ 88.15%

Conmed Technicals Summary

Sell

Neutral

Buy

Conmed is currently in a neutral trading position according to technical analysis indicators.

Conmed (CNMD) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Conmed Corp logo
-20.97%
-22.49%
-31.91%
-58.94%
-58.4%
Medtronic Plc logo
3.4%
5.22%
9.95%
-11.8%
1.8%
Edwards Lifesciences Corp. logo
2.13%
10.35%
-17.53%
-32.76%
14.39%
Boston Scientific Corp. logo
1.13%
28.68%
55.31%
146.09%
207.16%
Stryker Corporation logo
0.84%
10.53%
11.46%
56.15%
129.21%
Abbott Laboratories logo
6.67%
21.76%
15.39%
15.86%
78.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Conmed Corp logo
13.55
13.55
5.29
4.34
0.15
0.04
0.01
31.15
Medtronic Plc logo
28.71
28.71
1.91
5.45
0.08
0.05
0.03
38.49
Edwards Lifesciences Corp. logo
31.13
31.13
5.57
2.45
0.17
0.08
NA
16.99
Boston Scientific Corp. logo
84.24
84.24
1.87
2.86
0.09
0.05
NA
14.76
Stryker Corporation logo
50.77
50.77
2.91
13.49
0.15
0.07
0.01
54.1
Abbott Laboratories logo
18.34
18.34
2.52
5.15
0.31
0.06
0.02
27.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Conmed Corp logo
Buy
$1.8B
-58.4%
13.55
10.13%
Medtronic Plc logo
Buy
$119.3B
1.8%
28.71
12.83%
Edwards Lifesciences Corp. logo
Buy
$42.8B
14.39%
31.13
76.75%
Boston Scientific Corp. logo
Buy
$152.9B
207.16%
84.24
11.07%
Stryker Corporation logo
Buy
$148.8B
129.21%
50.77
13.25%
Abbott Laboratories logo
Buy
$238.6B
78.8%
18.34
31.95%

Conmed Dividend announcements

  • Conmed Dividends March, 2025

    In the quarter ending March,2025. Conmed has declared dividend of $0.20

About Conmed

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, the company offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention; and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.
Organization
Conmed
Employees
3900
CEO
Mr. Patrick J. Beyer
Industry
Health Technology

Management People of Conmed

NameTitle
Mr. Patrick J. Beyer
President, CEO & Director
Mr. Todd W. Garner CPA
Executive VP, CFO & Principal Accounting Officer
Mr. Curt R. Hartman
Advisor
Mr. Richard Glaze
Chief Information Officer
Ms. Hollie Foust
Executive VP, General Counsel and Corporate Secretary
Mr. Peter K. Shagory
Executive Vice President of Strategy & Corporate Development
Ms. Shanna L. Cotti-Osmanski
Executive VP of Information Technology & CIO
Mr. John Ferrell
Executive Vice President of Human Resources
Mr. David R. Murray
President of ConMed Electrosurgery
Ms. Johonna Marie Pelletier CPA
VP of Tax & Treasurer

Important FAQs about investing in CNMD Stock from India :

What is Conmed share price today?

Conmed share price today stands at $57.60, Open: $58.28 ; Previous Close: $57.70 ; High: $59.07 ; Low: $56.85 ; 52 Week High: $86.96 ; 52 Week Low: $55.22.

The stock opens at $58.28, after a previous close of $57.70. The stock reached a daily high of $59.07 and a low of $56.85, with a 52-week high of $86.96 and a 52-week low of $55.22.

Can Indians buy Conmed shares?

Yes, Indians can invest in the Conmed (CNMD) from India.

With INDmoney, you can buy Conmed at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Conmed at zero transaction cost.

How can I buy Conmed shares from India?

It is very easy to buy Conmed from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Conmed (CNMD) be purchased?

Yes, you can buy fractional shares of Conmed with INDmoney app.

What are the documents required to start investing in Conmed stocks?

To start investing in Conmed, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Conmed Stock (CNMD)?

Today’s highest price of Conmed (CNMD) is $59.07.

Today’s lowest price of Conmed (CNMD) is $56.85.

What is today's market capitalisation of Conmed?

Today's market capitalisation of Conmed CNMD is 1.8B

What is the 52 Week High and Low Range of Conmed Stock (CNMD)?

  • 52 Week High

    $86.96

  • 52 Week Low

    $55.22

What are the historical returns of Conmed (CNMD)?

  • 1 Month Returns

    -20.97%

  • 3 Months Returns

    -22.49%

  • 1 Year Returns

    -31.91%

  • 5 Years Returns

    -58.4%

Who is the Chief Executive Officer (CEO) of Conmed ?

Mr. Patrick J. Beyer is the current Chief Executive Officer (CEO) of Conmed.